Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Monopar Therapeutics (MNPR) Shares Issued (2017 - 2020)

Historic Shares Issued for Monopar Therapeutics (MNPR) over the last 3 years, with Q3 2020 value amounting to -$1.4 million.

  • Monopar Therapeutics' Shares Issued changed N/A to -$1.4 million in Q3 2020 from the same period last year, while for Sep 2020 it was $10.2 million, marking a year-over-year change of. This contributed to the annual value of $37.4 million for FY2024, which is 170205.36% up from last year.
  • Latest data reveals that Monopar Therapeutics reported Shares Issued of -$1.4 million as of Q3 2020.
  • Monopar Therapeutics' 5-year Shares Issued high stood at $10.2 million for Q4 2019, and its period low was -$1.4 million during Q3 2020.
  • For the 3-year period, Monopar Therapeutics' Shares Issued averaged around $1.9 million, with its median value being $951763.5 (2017).